
Articles
-
3 days ago |
medicalnewstoday.com | Amber Watson
Rexulti (brexpiprazole) may not be safe to take while pregnant or breastfeeding. Certain factors, including risks associated with not treating your health condition during pregnancy, may determine whether you should take the drug during this time. If you may be or can become pregnant, it’s important to consider whether Rexulti is a safe option for you.
-
2 weeks ago |
medicalnewstoday.com | Amber Watson
Tremfya (guselkumab) is a brand-name subcutaneous injection that’s prescribed for moderate to severe plaque psoriasis. This article covers topics such as side effects, how Tremfya works, and cost. Tremfya is a biologic and belongs to a drug class called interleukin-23 blockers. The medication is not available in a biosimilar version. Read on for details about Tremfya for plaque psoriasis. Plaque psoriasis is an autoimmune condition that affects the skin and nails.
-
2 weeks ago |
medicalnewstoday.com | Amber Watson
Dulera has possible interactions with some other drugs and certain supplements. Examples include furosemide (Furoscix, Lasix) and metoprolol (Lopressor, Toprol XL, others). Talk with your doctor to avoid potentially harmful effects from Dulera interactions. Dulera is prescribed for asthma in adults and children ages 5 years and older. An interaction occurs when one substance causes another substance to have a different effect than expected.
-
3 weeks ago |
medicalnewstoday.com | Amber Watson
It’s not known whether Xywav (calcium, magnesium, potassium, and sodium oxybates) is safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy may determine whether you should take the drug during this time. It’s not known whether you should take Xywav during pregnancy.
-
1 month ago |
medicalnewstoday.com | Amber Watson
Gomekli is a brand-name drug prescribed for certain noncancerous tumors. The medication is available as an oral capsule and oral tablet. Specifically, the Food and Drug Administration (FDA) has approved Gomekli to treat neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). With this condition, noncancerous tumors grow on nerves outside the brain and spinal cord. Gomekli is used to treat NF1-PN in certain adults and children ages 2 years and older.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →